Benjamin Blencowe | |
---|---|
![]() | |
Born | Benjamin Joseph Blencowe |
Nationality | British and Canadian |
Alma mater | Imperial College London (BSc) University of London (PhD) |
Awards | John Polanyi Award (2011) |
Scientific career | |
Fields | Gene regulation RNA processing Alternative splicing Functional genomics[1] |
Institutions | |
Thesis | The application of antisense technology to the study of mammalian pre-mRNA splicing factors. (1991) |
Academic advisors |
|
Website | http://sites.utoronto.ca/intron/index.html |
Benjamin Joseph BlencoweFRS FRSC[2][3] is a British and Canadian molecular biologist, currently appointed as Professor and Banbury Chair in Medical Research at theUniversity of Toronto. He also serves as Director of the University of Toronto’s Donnelly Sequencing Centre.[4][1] He teaches in the Department of Molecular Genetics and his lab is part of theDonnelly Centre for Cellular and Biomolecular Research.
Blencowe studied microbiology andmolecular biology atImperial College London, where he received an BSc (with first class honours) in 1988. He undertook graduate research at theEuropean Molecular Biology Laboratory, as an external student of theUniversity of London, earning hisPhD in 1991.
After receiving his PhD, Blencowe joined the Center of Cancer Research (renamedKoch Institute for Integrative Cancer Research) at theMassachusetts Institute of Technology as a Human Frontier Science Program Long Term Fellow in 1992. He was appointed Assistant Professor atUniversity of Toronto in 1998 and promoted to full Professor in 2006.
Blencowe’s research focuses on fundamental questions relating toRNA biology.[1] His research group has made pioneering contributions to the development and application of high-throughput methods for studyingRNA processing and RNA-RNA interactions. This research has contributed global-scale insights into the complexity, evolution, regulation and function ofalternative splicing, including the discovery of splicing networks that controlstem cellpluripotency andneurogenesis. His most recent research led to the discovery of a program of alternative splicing that is commonly disrupted in neurological disorders, work that has opened the door to a new therapeutic strategy forautism.
Blencowe received the Premier of Ontario Research Excellence Award in 1999 and the Canadian Society of Molecular Biosciences Senior Investigator Award in 2011.[5] He was a recipient of the Natural Sciences and Engineering Research Council of Canada John C. Polanyi Award in 2011 for his contributions to the understanding of the RNA splicing code.[6] Blencowe was electedFellow of the Royal Society of Canada (FRSC) in 2017,[3] andFellow of the Royal Society (FRS) in 2019.[2]
“All text published under the heading 'Biography' on Fellow profile pages is available underCreative Commons Attribution 4.0 International License.” --Royal Society Terms, conditions and policies at theWayback Machine (archived 2016-11-11)